Cargando…

The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans

Intranasal delivery provides a practical, noninvasive method of bypassing the blood-brain barrier (BBB) in order to deliver therapeutic agents to the brain. This method allows drugs that do not cross the BBB to be delivered to the central nervous system in a few minutes. With this technology, it wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Rodríguez, Julio Cesar, Sosa Teste, Iliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823095/ https://www.ncbi.nlm.nih.gov/pubmed/19768354 http://dx.doi.org/10.1100/tsw.2009.103

Ejemplares similares

Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia
por: Rodríguez Cruz, Yamila, et al.
Publicado: (2010)

Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
por: Teste, Iliana Sosa, et al.
Publicado: (2012)

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013)

Enhancing the Delivery of Erythropoietin and Its Variants into the Ischemic Brain
por: Hermann, Dirk M.
Publicado: (2009)

Correlation between Serum Erythropoietin and Cerebral Collateral Flow in Acute Ischemic Stroke Patient
por: Yun, Sung Won, et al.
Publicado: (2023)

The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review
por: Ma, Yuanyuan, et al.
Publicado: (2022)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke
por: Yip, Hon-Kan, et al.
Publicado: (2011)

Effect of erythropoietin therapy on clinical outcome in patients after acute ischemic stroke: a debatable issue
por: Yuen, Chun-Man, et al.
Publicado: (2011)

Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
por: Hermann, Dirk M.
Publicado: (2010)

Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system
por: Simon, Florian, et al.
Publicado: (2019)

Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
por: Ahmed, Osama A. A., et al.
Publicado: (2020)

Recombinant human erythropoietin increases cerebral cortical width index and neurogenesis following ischemic stroke☆
por: Wen, Zhongmin, et al.
Publicado: (2012)

Intracerebral transplantation of erythropoietin‐producing fibroblasts facilitates neurogenesis and functional recovery in an ischemic stroke model
por: Chou, Pin‐Chun, et al.
Publicado: (2019)

Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief
por: Djupesland, Per G, et al.
Publicado: (2013)

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route
por: Abo El-Enin, Hadel A., et al.
Publicado: (2022)

Erythropoietin Pathway: A Potential Target for the Treatment of Depression
por: Ma, Chongyang, et al.
Publicado: (2016)

Women With Large Vessel Occlusion Acute Ischemic Stroke Are Less Likely to Be Routed to Comprehensive Stroke Centers
por: Tariq, Muhammad Bilal, et al.
Publicado: (2023)

Erythropoietin for stroke treatment: dead or alive?
por: Minnerup, Jens, et al.
Publicado: (2011)

Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke
por: Yuen, Chun-Man, et al.
Publicado: (2011)

Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke
por: Lv, Wen, et al.
Publicado: (2015)

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)

Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route
por: Upadhyay, Pratik, et al.
Publicado: (2017)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

EXPERIMENTS ON THE NASAL ROUTE OF INFECTION IN POLIOMYELITIS
por: Flexner, Simon, et al.
Publicado: (1920)

Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
por: Klopsch, Christian, et al.
Publicado: (2018)

Erythropoietin Amplifies Stroke-Induced Oligodendrogenesis in the Rat
por: Zhang, Li, et al.
Publicado: (2010)

Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study
por: Santos-Morales, Orestes, et al.
Publicado: (2017)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial
por: Tsai, Tzu-Hsien, et al.
Publicado: (2015)

Application of SPRA Technology for Delivery of Erythropoietin: Stability Evaluation of Conjugated Erythropoietin with Adamantane and in SPRA Inclusion Complex
por: Alizadeh, Bahareh, et al.
Publicado: (2023)

Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research
por: Oorschot, Dorothy E., et al.
Publicado: (2020)

Routing to Endovascular Treatment of Ischemic Stroke in Korea: Recognition of Need for Process Improvement
por: Kang, Jihoon, et al.
Publicado: (2020)

Regulated necrosis pathways: a potential target for ischemic stroke
por: Ren, Kaidi, et al.
Publicado: (2023)

Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential
por: Liu, Xiaoqing, et al.
Publicado: (2020)

Erratum to: Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial
por: Tsai, Tzu-Hsien, et al.
Publicado: (2016)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors
por: Jeong, Seung-Hyun, et al.
Publicado: (2022)

Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route
por: Verma, Hitesh, et al.
Publicado: (2014)

Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin
por: Yeh, Kuo-Ho, et al.
Publicado: (2012)

Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner
por: Thériault, Peter, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_alh9a5r3e8u982db393o4i36iv